欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5989/004
药品名称Leponex 200 mg Tabletten
活性成分
    • Clozapine 200.0 mg
剂型Tablet
上市许可持有人Viatris Healthcare GmbH Luetticher Strasse 5 53842 Troisdorf, Germany
参考成员国 - 产品名称Germany (DE)
Leponex 200 mg Tabletten
互认成员国 - 产品名称
    • Finland (FI)
    • Hungary (HU)
      Leponex 200 mg tabletta
    • Czechia (CZ)
      Leponex 200 mg tablety
    • Slovenia (SI)
    • Croatia (HR)
    • Belgium (BE)
      Leponex 200 mg tabletten
    • Luxembourg (LU)
    • Ireland (IE)
    • Spain (ES)
    • Greece (GR)
许可日期2024/10/01
最近更新日期2024/10/02
药物ATC编码
    • N05AH02 clozapine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase